G
LIVE

Serial Number

98241046

Owner

Galapagos NV

Attorney

Alexandra MacKay

Filing Date

Oct 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

G Trademark

Serial Number: 98241046 • Registration: 7562966

G is a trademark filed by Galapagos NV on October 26, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Galapagos NV (19 trademarks)

Mechelen B-2800 , BE

Entity Type: 03

Trademark Details

Filing Date

October 26, 2023

Registration Date

November 12, 2024

Published for Opposition

August 27, 2024

Goods & Services

Medical services; providing medical and pharmaceutical advice; gene bank services

Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; Biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes

Medical, scientific and industrial research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development services , namely configuration and customization of computer databases containing information regarding medical, pharmaceutical and biopharmaceutical information; Pharmaceutical drug development services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 12, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 9, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 2, 2023 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2023 NWOS
NEW APPLICATION ENTERED
Oct 30, 2023 NWAP